18518-46-2

Upstream product

• 13754-86-4 1,5,6,7-tetrahydro-indol-4-one 
• 98-09-9 benzenesulfonyl chloride 

Downstream Products

• 609368-71-0 1-benzenesulfonyl-4,5,6,7-tetrahydro-1H-indol-4-one (E)-oxime 
• 1192248-34-2 3-benzenesulfonyl-3,10-dihydropyrrolo[3,2-a]carbazole 
• 1227410-06-1 [1-(benzenesulfonyl)-4-(methylsulfanyl)-1H-indol-2-yl]borandiol 
• 1227410-05-0 1-(benzenesulfonyl)-4-methylsulfanyl-1H-indole 
• 95969-13-4 1-Benzenesulfonyl-4-hydroxy-1H-indole 
• 95969-08-7 1-benzenesulfonyl-5-chloro-4-oxo-4,5,6,7-tetrahydroindole 
• 27866-51-9 1-benzenesulfonyl-5-bromo-1,5,6,7-tetrahydro-indol-4-one 
• 108861-44-5 1-Benzenesulfonyl-4-benzenesulfonylmethyl-4,5,6,7-tetrahydro-1H-indol-4-ol 
• 108861-45-6 1-Benzenesulfonyl-4-methanesulfonylmethyl-4,5,6,7-tetrahydro-1H-indol-4-ol 
• 108861-49-0 1-(phenylsulfonyl)-4-<(phenylsulfonyl)methyl>indole 
• 108861-50-3 1-Benzenesulfonyl-4-methanesulfonylmethyl-1H-indole 

Relevant academic research and scientific papers

Synthesis of substituted 4-azaisoindoles - New tacrine analogues

The regioselective Friedlaender reaction of 3-amino-4-cyanopyrroles with a series of cyclic ketones has enabled the first reported synthesis of substituted 4-azaisoindoles. Structurally, this new class of compounds stands for the first reported 4-azaisoin

7-Substituted Purine Derivatives for Immunosuppression

The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula III:

7-SUBSTITUTED PURINE DERIVATIVES FOR IMMUNOSUPPRESSION

The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula (III).

PURINE AND IMIDAZOPYRIDINE DERIVATIVES FOR IMMUNOSUPPRESSION

The present invention provides novel purine and imidazopyridine derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formulas ( I ) and ( II ).

Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands

The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.